Peter Boyle

Summary

Affiliation: European Institute of Oncology
Country: Italy

Publications

  1. ncbi request reprint Cancer mortality in Ireland, 1926-1995
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Ann Oncol 14:323-32. 2003
  2. ncbi request reprint European Code Against Cancer and scientific justification: third version (2003)
    P Boyle
    Department of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Ann Oncol 14:973-1005. 2003
  3. ncbi request reprint Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?
    P Boyle
    European Institute of Oncology, Milan, Italy
    Ann Oncol 14:1312-25. 2003
  4. ncbi request reprint The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:409-14. 2003
  5. ncbi request reprint The epidemiology of prostate cancer
    Peter Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Urol Clin North Am 30:209-17. 2003
  6. ncbi request reprint Testicular cancer: the challenge for cancer control
    Peter Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Lancet Oncol 5:56-61. 2004
  7. ncbi request reprint Cancer control in women. Update 2003
    P Boyle
    Dept of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Int J Gynaecol Obstet 83:179-202. 2003
  8. ncbi request reprint Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy
    Umberto Veronesi
    Scientific Directorate, European Institute of Oncology, Milan, Italy
    J Natl Cancer Inst 99:727-37. 2007
  9. ncbi request reprint Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
    Sara Gandini
    Department of Epidemiology and Biostatistics, European Institute of Oncology, IRCCS Via Ripamonti 435, 20141 Milan, Italy
    Eur J Cancer 41:45-60. 2005
  10. ncbi request reprint Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial
    Andrea Decensi
    Divisions of Chemoprevention, European Institute of Oncology, Milan, Italy
    Circulation 111:650-6. 2005

Collaborators

Detail Information

Publications66

  1. ncbi request reprint Cancer mortality in Ireland, 1926-1995
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Ann Oncol 14:323-32. 2003
    ..The information presented here will contribute to providing a basis for the collaborative Cancer Research programme initiated recently...
  2. ncbi request reprint European Code Against Cancer and scientific justification: third version (2003)
    P Boyle
    Department of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Ann Oncol 14:973-1005. 2003
  3. ncbi request reprint Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?
    P Boyle
    European Institute of Oncology, Milan, Italy
    Ann Oncol 14:1312-25. 2003
    ..A programme of activities and research, focussing on three major themes [prevention (particularly tobacco control), screening, and education and training], was developed together with the European Code Against Cancer...
  4. ncbi request reprint The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:409-14. 2003
    ..To evaluate the epidemiology of lower urinary tract symptoms (LUTS) among men and women, as there are significant unanswered questions about the prevalence and impact of LUTS in different populations...
  5. ncbi request reprint The epidemiology of prostate cancer
    Peter Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Urol Clin North Am 30:209-17. 2003
    ....
  6. ncbi request reprint Testicular cancer: the challenge for cancer control
    Peter Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Lancet Oncol 5:56-61. 2004
    ..Testicular cancer control would be the finest illustration of this process and, simultaneously, would be a model for implementation as new, successful therapeutic modalities for other cancers are developed...
  7. ncbi request reprint Cancer control in women. Update 2003
    P Boyle
    Dept of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Int J Gynaecol Obstet 83:179-202. 2003
    ..Although more work is needed, it is becoming clear that there could be an important role of HPV testing to further enhance cervix cancer screening...
  8. ncbi request reprint Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy
    Umberto Veronesi
    Scientific Directorate, European Institute of Oncology, Milan, Italy
    J Natl Cancer Inst 99:727-37. 2007
    ..Here we present an extended follow-up of the Italian trial...
  9. ncbi request reprint Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
    Sara Gandini
    Department of Epidemiology and Biostatistics, European Institute of Oncology, IRCCS Via Ripamonti 435, 20141 Milan, Italy
    Eur J Cancer 41:45-60. 2005
    ....
  10. ncbi request reprint Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial
    Andrea Decensi
    Divisions of Chemoprevention, European Institute of Oncology, Milan, Italy
    Circulation 111:650-6. 2005
    ..Atherosclerosis may induce VTE, or the 2 conditions may share common risk factors. We assessed the effect of tamoxifen on VTE in a breast cancer prevention trial and studied its association with risk factors for VTE...
  11. ncbi request reprint Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors
    Sara Gandini
    Department of Epidemiology and Biostatistics, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
    Eur J Cancer 41:2040-59. 2005
    ..Sensitivity analyses investigated reliability of results and publication bias. Latitude and adjustment for phenotype were two study characteristics that significantly influenced the estimates...
  12. ncbi request reprint ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer
    Gianluca Severi
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    J Natl Cancer Inst 95:818-24. 2003
    ..In five of the seven total studies, subject selection was influenced by prostate-specific antigen (PSA) levels. We examined the association and possible effect of subject selection in a larger study and a meta-analysis...
  13. ncbi request reprint Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results
    Ugo Pastorino
    Division of Thoracic Surgery, Istituto Nazionale Tumori, Milan, Italy
    Lancet 362:593-7. 2003
    ..We investigated the efficacy of repeated yearly spiral CT and selective use of positron emission tomography (PET) in a large cohort of high-risk volunteers...
  14. ncbi request reprint An estimate of prostate cancer prevalence in Italy
    Carlo La Vecchia
    Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Tumori 88:367-9. 2002
    ..The number of clinically detected cases, including cases with advanced disease, is less subject to uncertainty, with reasonable estimates ranging from 45,000 to 60,000...
  15. ncbi request reprint Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women
    Umberto Veronesi
    European Institute of Oncology, Milan, Italy
    J Natl Cancer Inst 95:160-5. 2003
    ..Such a strategy would greatly reduce the numbers of women who would need to take tamoxifen to obtain the same absolute reduction in breast cancer. These findings are exploratory and need to be confirmed in other randomized trials...
  16. ncbi request reprint Tobacco smoking and cancer: a meta-analysis
    Sara Gandini
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Int J Cancer 122:155-64. 2008
    ..The analysis of heterogeneity showed that study type, gender and adjustment for confounding factors significantly influence the RRs estimates and the reliability of the studies...
  17. doi request reprint Past medical history and pancreatic cancer risk: Results from a multicenter case-control study
    Patrick Maisonneuve
    European Institute of Oncology, Milan, Italy
    Ann Epidemiol 20:92-8. 2010
    ..To investigate risk factors that may be linked to pancreatic cancer...
  18. ncbi request reprint Mouthwash and oral cancer risk quantitative meta-analysis of epidemiologic studies
    Sara Gandini
    European Institute of Oncology, Milan, Italy
    Ann Agric Environ Med 19:173-80. 2012
    ..A meta-analysis of epidemiological studies of mouthwash and oral cancer and, specifically, mouthwash containing >25% alcohol, was undertaken...
  19. ncbi request reprint A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia
    Peter Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 94:83-8. 2004
    ..To investigate the short- and long-term effectiveness of transurethral needle ablation (TUNA) of the prostate for clinical benign prostatic hyperplasia (BPH), using a meta-analysis of all clinical studies involving TUNA...
  20. ncbi request reprint Mammographic breast cancer screening: after the dust has settled
    Peter Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Breast 12:351-6. 2003
  21. ncbi request reprint Breast cancer
    Umberto Veronesi
    European Institute of Oncology, Milan, Italy
    Lancet 365:1727-41. 2005
    ..Assessment of potential molecular targets is now important in primary diagnosis. Tyrosine-kinase inhibitors and other drugs with anti-angiogenesis properties are currently undergoing preclinical investigations...
  22. ncbi request reprint Epidemiology of colorectal cancer
    Peter Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Br Med Bull 64:1-25. 2002
    ..Achieving colorectal cancer control is the immediate challenge...
  23. ncbi request reprint Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi
    Sara Gandini
    Department of Epidemiology and Biostatistics, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
    Eur J Cancer 41:28-44. 2005
    ..Case-control studies, in particular when the hospital was the source for cases or controls, appeared to present much lower and more precise estimates than cohort studies...
  24. ncbi request reprint The future of the nicotine-addiction market
    Nigel Gray
    Division of Epidemiology and Biostatistics, European Institute of Oncology, 20141, Milan, Italy
    Lancet 362:845-6. 2003
  25. ncbi request reprint Relation of childhood brain tumors to exposure of parents and children to tobacco smoke: the SEARCH international case-control study. Surveillance of Environmental Aspects Related to Cancer in Humans
    Graziella Filippini
    Neuroepidemiology Research Unit, Istituto Nazionale Neurologico C Besta, Milan, Italy
    Int J Cancer 100:206-13. 2002
    ..These results did not change considering the child's age at diagnosis, the histologic type of tumor or center...
  26. ncbi request reprint A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma
    Yawei Zhang
    Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT 06520 8034, USA
    J Natl Cancer Inst 97:1616-8. 2005
    ..2, 95% CI = 2.0 to 13.3). Our results support the hypothesis that a genetic variant that could alter mRNA transcripts of BCL6 may contribute to the etiology of NHL and suggest that this variant warrants further investigation...
  27. ncbi request reprint Mortality and survival in breast and colorectal cancer
    Peter Boyle
    International Agency for Research on Cancer, Lyon, France
    Nat Clin Pract Oncol 2:424-5. 2005
  28. ncbi request reprint Breast cancer control: signs of progress, but more work required
    Peter Boyle
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex08, France
    Breast 14:429-38. 2005
    ..The declines seen in mortality represent a considerable success, but there is no room for complacency until research can impact positively on reducing incidence...
  29. ncbi request reprint Declining mortality from bladder cancer in Europe
    Jacques Ferlay
    International Agency for Research on Cancer, Lyon Cedex, France
    BJU Int 101:11-9. 2008
    ....
  30. ncbi request reprint Circulating steroid hormones and the risk of prostate cancer
    Gianluca Severi
    Cancer Epidemiology Centre, The Cancer Council Victoria, University of Melbourne, Melbourne, Australia
    Cancer Epidemiol Biomarkers Prev 15:86-91. 2006
    ..06, 0.2, and 0.1, respectively). High levels of testosterone and adrenal androgens are thus associated with reduced risk of aggressive prostate cancer but not with nonaggressive disease...
  31. ncbi request reprint Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident
    Elisabeth Cardis
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 119:1224-35. 2006
    ....
  32. ncbi request reprint Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer
    Gianluca Severi
    Cancer Epidemiology Centre, Cancer Council Victoria, 1 Rathdowne Street, Carlton, Victoria 3053, Australia
    Cancer Epidemiol Biomarkers Prev 15:1137-41. 2006
    ..49 (95% confidence interval, 1.11-2.00). The HRs did not differ by tumor aggressiveness or age at onset (all Ps > or = 0.4). In our study, high levels of IGFBP-3 but not IGF-I were associated with an increased risk of prostate cancer...
  33. ncbi request reprint Tobacco: deadly in any form or disguise
    Peter Boyle
    International Agency for Research on Cancer, 69372 Lyon, France
    Lancet 367:1710-2. 2006
  34. ncbi request reprint Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA
    Gianluca Severi
    Cancer Epidemiology Center, The Cancer Council Victoria, Melbourne, Victoria, Australia
    Cancer Epidemiol Biomarkers Prev 15:1142-7. 2006
    ..The genotypes and haplotypes studied might be associated with the PSA gene function or be in linkage disequilibrium with other unmeasured and functional variants in the PSA or other genes...
  35. ncbi request reprint The globalisation of cancer
    Peter Boyle
    International Agency for Research on Cancer, 69372 Lyon Cedex, France
    Lancet 368:629-30. 2006
  36. ncbi request reprint 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
    Vanessa M Hayes
    Cancer Research Program, Garvan Institute of Medical Research, St Vincent s Hospital, Sydney, Australia
    Int J Cancer 120:776-80. 2007
    ..These findings raise important questions with respect to previous assumptions concerning hormonal influences on prostate cancer risk in ageing males...
  37. ncbi request reprint 'Environment' in cancer causation and etiological fraction: limitations and ambiguities
    Paolo Boffetta
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69008 Lyon, France
    Carcinogenesis 28:913-5. 2007
  38. doi request reprint Artificial ultraviolet sources and skin cancers: rationale for restricting access to sunbed use before 18 years of age
    Philippe Autier
    International Agency for Research, Lyon, France
    Nat Clin Pract Oncol 5:178-9. 2008
  39. ncbi request reprint The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies
    Chris Robertson
    University of Strathclyde, Glasgow, Scotland, UK
    BJU Int 99:347-54. 2007
    ..To investigate the effect of lower urinary tract symptoms (LUTS) on quality of life (QoL) and to determine its extent across a variety of cultures, and the confounding effects of self-reported comorbidities and demographics...
  40. ncbi request reprint Screening for prostate cancer: updated experience from the Tyrol study
    Wolfgang Horninger
    Department of Urology, University of Innsbruck, Innsbruck, Austria
    Can J Urol 12:7-13; discussion 92-3. 2005
    ....
  41. ncbi request reprint Cigarette smoking, glutathione-s-transferase M1 and t1 genetic polymorphisms, and breast cancer risk (United States)
    Tongzhang Zheng
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06510, USA
    Cancer Causes Control 13:637-45. 2002
    ..We sought to determine if there is a gene-environment interaction between GSTM I (GSTM1A and GSTM1B), and GSTT1 genotypes and cigarette smoking in the risk of breast cancer...
  42. ncbi request reprint Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand
    John H Stewart
    Department of Medical and Surgical Sciences, University of Otago, Dunedin, New Zealand
    J Am Soc Nephrol 14:197-207. 2003
    ....
  43. ncbi request reprint Recent trends in mortality from benign prostatic hyperplasia
    Fabio Levi
    Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Medecine Sociale et Preventive, CHUV Falaises 1, 1011 Lausanne, Switzerland
    Prostate 56:207-11. 2003
    ..We have considered trends in mortality from benign prostatic hyperplasia (BPH) over the last decades in Europe and, for comparative purposes, the USA and Japan...
  44. ncbi request reprint Androgenetic alopecia and prostate cancer: findings from an Australian case-control study
    Graham G Giles
    Cancer Epidemiology Centre, Anti Cancer Council of Victoria, Melbourne, VIC 3053 Australia
    Cancer Epidemiol Biomarkers Prev 11:549-53. 2002
    ..91 (1.59-5.32) for vertex baldness; and 1.95 (1.10-3.45) for frontal and vertex baldness. This association between the pattern of AA and prostate cancer points to shared androgen pathways that are worthy of additional investigation...
  45. ncbi request reprint Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States)
    Lindsay McOmber Morton
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Cancer Causes Control 14:687-94. 2003
    ..Data from a population-based case-control study among women in Connecticut were analyzed to determine the potential impact of alcohol consumption on risk of NHL...
  46. ncbi request reprint Tobacco control, screening, and collaboration are priorities for IARC, incoming director says. Interview with Peter Boyle
    Peter Boyle
    J Natl Cancer Inst 95:1653-5. 2003
  47. ncbi request reprint Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)
    Raymond Rosen
    Department of Psychiatry, Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854, USA
    Eur Urol 44:637-49. 2003
    ..This study was conducted to investigate the relationship between LUTS and sexual problems in aging men...
  48. ncbi request reprint Cancer of the skin: a forgotten problem in Europe
    Peter Boyle
    Ann Oncol 15:5-6. 2004
  49. ncbi request reprint Foods, nutrients and prostate cancer
    Allison M Hodge
    Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia
    Cancer Causes Control 15:11-20. 2004
    ..To examine the risk of prostate cancer associated with foods and nutrients, including individual fatty acids and carotenoids...
  50. ncbi request reprint The role of the dental team in preventing and diagnosing cancer: 1. cancer in general
    Crispian Scully
    Eastman Dental Institute for Oral Health Care Sciences, University College London, 256 Gray s Inn Road, London WC1X 8LD
    Dent Update 32:204-6, 208-10, 212. 2005
    ..The signs and symptoms of cancer often resemble less serious conditions and prompt referral to an appropriate specialist usually allows for the best management...
  51. ncbi request reprint Leveling of prostate cancer mortality in Western Europe
    Fabio Levi
    Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Medecine Sociale et Preventive, Lausanne, Switzerland
    Prostate 60:46-52. 2004
    ..Trends in 24 European countries, the European Union (EU), six selected Central and Eastern European countries, and the Russian Federation have been updated to 1999...
  52. ncbi request reprint Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women
    Yawei Zhang
    Department of Epidemiology and Public Health, School of Medicine, Yale University, New Haven, CT 06510, USA
    Am J Epidemiol 160:1177-83. 2004
    ..In summary, the CYP1A1 m2 genetic polymorphism was associated with increased risk of female breast cancer and may modify the relation between PCB exposure and breast cancer risk...
  53. ncbi request reprint Screening for prostate cancer: updated experience from the Tyrol study
    Wolfgang Horninger
    Department of Urology, University of Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
    Curr Urol Rep 5:220-5. 2004
    ..It is our opinion that most of this decline is likely a result of aggressive downstaging and successful treatment and that any contribution from detecting and treating early cancers will become apparent in the years to come...
  54. ncbi request reprint Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women
    Yawei Zhang
    Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT, USA
    Am J Epidemiol 160:325-30. 2004
    ..In summary, the authors' findings do not support the hypothesis that allogeneic blood transfusion increases the risk of non-Hodgkin's lymphoma...
  55. ncbi request reprint The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels
    Gianluca Severi
    Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria 3053, Australia
    BJU Int 101:492-6. 2008
    ..To use a large population-based case-control study to test the association between the common genetic variant rs743572 (-34 T to C), prostate cancer risk and circulating levels of several hormones...
  56. doi request reprint The changing pattern of kidney cancer incidence and mortality in Europe
    Fabio Levi
    Unité d épidemiologie du cancer et Registres des tumeurs de Vaud et Neuchâtel, Institut de Medecine Sociale et Preventive, Centre Hospitalier Universitaire Vaudois et Universite de Lausanne, Lausanne, Switzerland
    BJU Int 101:949-58. 2008
    ....
  57. pmc Publishing tobacco tar measurements on packets
    Nigel Gray
    BMJ 329:813-4. 2004
  58. ncbi request reprint Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
    Claus G Roehrborn
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
    Urology 60:434-41. 2002
    ..To study the efficacy and safety of dutasteride, a dual inhibitor of the 5-alpha-reductase isoenzymes types I and II...
  59. ncbi request reprint Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women
    Lindsay McOmber Morton
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
    Cancer Epidemiol Biomarkers Prev 13:425-30. 2004
    ..To further investigate the link between HCV and NHL, we conducted HCV testing on serum samples of 998 women (464 cases; 534 controls) from a population-based case-control study of women in Connecticut...
  60. ncbi request reprint Is FOB screening really the answer for lowering mortality in colorectal cancer?
    Philippe Autier
    Centre for Research in Epidemiology CRESIS, Luxembourg Health Institute, Luxembourg, Luxembourg
    Recent Results Cancer Res 163:254-63; discussion 264-6. 2003
    ..Therefore, recommending general population screening with biennial FOBT is still an open question...
  61. ncbi request reprint Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women
    Yawei Zhang
    Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT, USA
    Am J Epidemiol 160:766-73. 2004
    ..These findings support a reduced risk of non-Hodgkin's lymphoma associated with multiple pregnancies and an increased risk of non-Hodgkin's lymphoma associated with later age at menarche...
  62. ncbi request reprint Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma
    Yawei Zhang
    Yale University School of Epidemiology and Public Health, New Haven, CT 06520 8034, USA
    Am J Epidemiol 165:1255-64. 2007
    ..0051). The risk appears to vary by non-Hodgkin's lymphoma subtypes. Further investigations of the role of ultraviolet radiation on the risk of non-Hodgkin's lymphoma are warranted...
  63. ncbi request reprint Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma
    Qing Lan
    Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, EPS 8109, Bethesda, MD 20892 7240, USA
    Hum Genet 121:161-8. 2007
    ..013), but was also associated with non-significant increased risks for each of the common B-cell histologies. These results suggest that SNPs in genes related to the oxidative stress pathway may be associated with increased risk of NHL...
  64. pmc Does "clock" matter in prostate cancer?
    Yong Zhu
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520, USA
    Cancer Epidemiol Biomarkers Prev 15:3-5. 2006
    ..Confirmation of this hypothesis will add to our understanding of the role of the circadian clock in prostate tumorigenesis and further facilitate the development of novel risk and prognostic biomarkers for prostate cancer...
  65. ncbi request reprint Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut
    Yawei Zhang
    Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT 06510, USA
    Am J Epidemiol 159:148-54. 2004
    ..Further studies are warranted to show whether the observed association reflects the change in hair dye formula contents during the past two decades or indicates that recent users are still in their induction and latent periods...
  66. ncbi request reprint The prevalence of urinary incontinence in community-dwelling married women: a matter of definition
    Vera Vandoninck
    Department of Urology, University Medical Center, Nijmegen, The Netherlands
    BJU Int 94:1291-5. 2004
    ..To determine the prevalence of female urinary incontinence (UI) and its impact on quality of life...